Latest filing published 01 Jun 2026 for Dexcom Inc.
Richard Alexander Collins sits on the board of Dexcom Inc, a Nasdaq company, and the 30 filings run from June 5, 2017 to June 1, 2026. Four are sales, worth EUR 2,223,830 in total with a median of EUR 513,435. The largest, EUR 1,049,436, dates from February 18, 2020; the second, EUR 838,189, from November 3, 2021; the most recent, EUR 188,681, from November 10, 2025.
The record holds no purchase. It does count 12 share grants and 14 filings of another kind. Activity stays calm and continuous: 2 to 5 filings a year, with 5 in 2025 and 1 in 2026.
Publication takes a median of 4 days. Of the 3 filings in the last twelve months, 2 are sales. Trades by Collins within 30 days of colleagues at Dexcom Inc number 2, 2 and 2. Every one in the same direction. In the same order, the colleagues are Bridgette P. Heller, Kevin R. Sayer and Mark G. Foletta.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations